Introduction
Hydrogen sulfide (H 2 S) is a gaseous chemical messenger which has been implicated in a multitude of physiologic processes. H 2 S arises from the amino acid cysteine via a reaction catalyzed by cystathionine ␥ -lyase (CSE), cystathionine ␤ -synthase (CBS) and 3-mercaptopyruvate sulfurtransferase [1, 2] . Recently, H 2 S activity has been found to be of considerable consequence in carotid body function. Acute administration of the CBS inhibitors hydroxylamine (HA) and amino-oxyacetic acid (AOAA) as well as chronic administration of the CSE inhibitor propargylglycine (PAG) diminish ex vivo carotid body responsiveness to hypoxia and hypercapnia [3, 4] . Furthermore, a blunted hypoxic responsiveness occurs in vivo in Kunming mice administered HA and AOAA [3] as well as mice with knockout mutations for CSE [4] . In addition, the discharge rate of rhythmic respiratory activity in isolated medullary sections from neonatal rats will decrease in response to HA and increase with administration of the CBS substrate cysteine, suggesting a potential role for H 2 S signaling in central respiratory control [5] . These observations imply that the pathways influencing H 2 S synthesis and activity could be targets of drug therapy for disorders of ventilatory control including unstable breathing disorders seen in a variety of medical and neurologic conditions [6] .
Key Words
Hypoxia ؒ Respiratory control ؒ Apnea ؒ Hydrogen sulfide Abstract Background: H 2 S synthesis inhibitors (HSSI) have been shown to impact respiratory control. For instance, the HSSI hydroxylamine (HA) decreases the respiratory discharge rate from isolated medullary sections, and HA in addition to other HSSIs propargylglycine and amino-oxyacetic acid (AOAA) have been found to reduce hypoxic responsiveness. Objectives: The aim of this study was to determine if administration of HSSIs could improve respiratory stability in an intact organism prone to recurrent central apneas. Methods: Saline and HSSI compounds were administered to C57BL/6J mice (n = 24), a strain predisposed to recurrent central apneas, prior to measurement of hypoxic and posthypoxic ventilatory behavior. Results: Administration of HA and AOAA resulted in a significantly smaller percentage of animals expressing one or more apneas during reoxygenation compared to saline control, and animals given AOAA demonstrated a smaller coefficient of variation for frequency during reoxygenation, a marker suggesting greater respiratory stability. This occurred despite varying effects of the three HSSI compounds on hypoxic ventilatory response. Conclusions: Instability and pause expression are improved by targeting H 2 S synthesis, an effect not predicted by effects on hypoxic responsiveness.
The C57BL/6J (B6) strain of mouse exhibits unstable breathing marked by recurrent apneas and an increased coefficient of variation (CV) for breath to breath respiratory frequency; this behavior is particularly prominent in the reoxygenation period following hypoxic exposure [7] . Posthypoxic instability in the B6 improves following administration of the carbonic anhydrase inhibitor acetazolamide and the serotonin 5-HT 1A partial agonist buspirone [8, 9] . In these studies and in those involving genetic manipulations, a relationship between chemoresponsiveness and apnea presence cannot be inferred by direct comparisons.
In the current study, we attempt to elucidate whether administration of hydrogen sulfide synthesis inhibitors (HSSI) will result in alterations in the posthypoxic respiratory instability of the B6 mouse. We anticipated that an attenuation of respiratory responsiveness to hypoxia will reduce the propensity for posthypoxic respiratory instability, implying a reducing effect on loop gain [10, 11] .
Materials and Methods

Animals
Experiments were performed on 10-week-old male C57BL/6J mice (n = 24; Jackson Laboratory). Animals were housed at the Louis Stokes Veterans Affairs Medical Center Animal Research Facility for 1 week prior to testing (food and water ad libitum; 12: 12-hour consistent light-dark cycle). The protocol was approved by the Louis Stokes Veterans Affairs Medical Center Animal Care and Use Committee and is consistent with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals.
Experimental Protocol
The mice were divided into groups of 6 animals. Ventilatory behavior in each group was first measured following intraperitoneal (i.p.) saline injection, and 3 days later ventilatory behavior was measured following i.p. administration of a HSSI which was different for each group of 6 animals. The HSSI consisted of either HA (300 mol/kg; Sigma), HA (600 mol/kg; Sigma), AOAA (300 mol/kg; Sigma), or PAG (1,800 mol/kg; Sigma). Note that this study uses a dose of HA at 600 mol/kg which is higher than that previously used [3] . This was done due to enhanced effects on reducing apneic activity noted during preliminary testing.
Ventilatory behavior was tested via whole body plethysmography using an apparatus which has been used and described previously by this laboratory [7, 8, 12] . To minimize effects of circadian rhythm, testing was performed between 10 a.m. and 2 p.m. Animals were placed in the plethsymography chamber for a 45-min acclimatization period, and at the end of this period, rectal temperatures were obtained and animals received an i.p. injection of either saline or one of the HSSI formulations. Following this injection, the animals experienced another 15-min acclimatization period. Baseline breathing was measured for 1 min at the end of acclimatization followed by a 5-min hypoxic challenge with poikilocapnic gas (8% O 2 , bal-N 2 ). The hypoxic challenge was then followed by a 5-min reoxygenation period with 100% O 2 . Rectal temperatures were also obtained following the reoxygenation period. Rectal temperatures were not performed during the hypoxic or reoxygenation periods so as to avoid disruption of ventilatory behavior.
Analysis of Respiratory Data
The plethysmography data were analyzed using a program custom written for our lab (Breath Detect) which was created to be compatible with data obtained in Lab View 9.0 (National Instruments). Data were scored from continuous recordings over 60-second time periods in the first and fifth minutes of each challenge and the 1 min of resting breathing following acclimation. Sniffs and sighs were excluded from analysis.
At rest and for each challenge, the values of frequency (f) , tidal volume (V T ), and minute ventilation (V E ) (with V T and V E normalized for weight) were compared between saline and each HSSI group. To investigate for short-term potentiation (STP) and posthypoxic frequency decline (PHFD), baseline f was compared to the f seen during the first minute of reoxygenation. The primary endpoint of our study was the presence or absence of one or more apneas during the first minute of reoxygenation, with apneas being defined as an absence of breathing activity, as measured by plethysmography, lasting longer than two breaths. The CV for respiratory frequency has been used previously as a marker of respiratory stability in rodents [13] [14] [15] and was calculated for each animal at rest and during the posthypoxic/reoxygenation period. CV and the presence or absence of apneic episodes were compared between saline and each HSSI group.
To assess the effect of HSSI administration on body temperature, pretesting (pre-injection) and posttesting rectal temperatures were compared between each HSSI administration and saline. Pre-and posttesting temperatures were also compared to each other within groups. Chamber temperature remained constant at 21.8 8 0.1 ° C.
In order to assess the effects of HSSI administration on body temperature, independent of changes in environmental oxygen, rectal temperatures were taken in age-matched B6 mice who were not tested in the plethysmography chamber (n = 3 per group). Rectal temperatures were obtained prior to injection, and at 1, 5, 10, 20 and 30 min following i.p. injection. Postinjection rectal temperatures in HSSI groups and saline were compared to preinjection temperature within groups, and postinjection temperatures in HSSI groups were also compared to saline.
Analysis
In comparing the HSSI and saline groups for postinjection temperature, CV, f , V T and V E , one-way ANOVA was used to detect significant differences among groups, and post hoc Dunnett's test compared each group to saline. Comparisons within groups (such as pre-and postintervention temperature, PHFD and STP), were accomplished with a paired t test for means. Z test for proportions was used to compare the percentage of animals per group expressing one or more apneas. In each analysis, p ! 0.05 was used as the threshold for significance. Values are expressed as means 8 standard error.
Results
F, T V , and V E during Rest, Hypoxia and Reoxygenation
At rest, following i.p. injection, f and V E were found to vary by injection group . By post hoc analysis, f was significantly lower than saline control in animals receiving PAG and AOAA, and V E was decreased in AOAA ( fig. 1 ). During hypoxia, AOAA resulted in blunted f, V T and V E compared to saline ( fig. 2 ). During reoxygenation following hypoxia, AOAA-injected animals again possessed blunted f, V T and V E compared to saline ( fig. 3 ).
Resting Respiratory Stability
Compared to saline administration, no HSSI group experienced a significant difference in the percentage of animals experiencing one or more apneas ( fig. 4 ) . Administration group contributed significantly to CV during resting breathing (p ! 0.01), but post hoc Dunnett's test failed to demonstrate any one group which varied sig- nificantly from saline, although there was a trend towards significance in the HA (300 mol/kg) group (Q = 2.517, critical Q = 2.535). The HA (300 mol/kg) group experienced a lower CV than saline ( fig. 5 ).
Posthypoxic Respiratory Stability
Upon comparison of resting and first-minute reoxygenation f by paired t test, saline-administered animals exhibited PHFD, whereas PAG administration resulted in STP ( fig. 6 ).
The percentage of animals possessing one or more apneas during reoxygenation was significantly less than saline for HA (600 mol/kg) and AOAA by z test for proportions ( fig. 7 ) .
Another marker of respiratory stability, the CV for breath-to-breath f, also varied as a function of administration group (p ! 0.01). The AOAA administration group demonstrated a lower CV for f during reoxygenation ( fig. 8 ).
Temperature Effects
When resting and postexposure rectal temperatures were compared by paired t test, animals in each administration group experienced acute hypoxia-induced ana- pyrexia (saline, p ! 0.001; HA 300 mol/kg, p ! 0.05; HA 600 mol/kg, p ! 0.001; AOAA, p ! 0.001; PAG, p ! 0.05); however, the anapyrexia occurred to varying degrees and significant postexposure differences among groups existed (p ! 0.001). Significantly lower postexposure differences compared to saline existed for AOAA administration. No pre-injection temperature differences among groups were found by ANOVA ( fig. 9 ). In contrast, without hypoxic stimulus, no differences were found by paired t test in any administration group between rectal temperature prior to i.p. injection and rectal temperature 30 min following injection (note that the When all postinjection temperatures (not just those recorded at 30 min after injection) were compared to preinjection temperatures by ANOVA, no significant changes from baseline were observed. When postinjection temperature was compared among groups, significant differences existed (p ! 0.001). Post hoc Dunnett's test revealed that the HA (600 mol/kg) group demonstrated a slight but significantly higher mean postinjection temperature than saline (saline 35.2 8 0.10 ° C, HA 600 mol/kg 35.9 8 0.12 ° C; fig. 10 ).
Discussion
This study demonstrates that, compared to saline, administration of the HSSI HA and AOAA results in a decreased incidence of apnea in the C57BL/6J mouse strain during the acute posthypoxic period. This occurred despite some disparity among inhibitors in their effect on hypoxic response. Additionally, AOAA administration resulted in a reduced CV in reoxygenation f . Finally, STP, a promoting factor for respiratory stability [16] , was observed in the PAG group. Consistent with previous reports, AOAA administration (300 mol/kg) resulted in a blunted response to hypoxia, and acute (approx. 15 min) PAG administration did not alter hypoxic responsiveness [3, 4] . The current study does not demonstrate a decreased V E during hypoxia with the administration of HA (300 mol/kg), as has been described previously [3] . This discrepancy is perhaps secondary to the limitation of whole body plethysmography in measuring V T depending on humidity and temperature differences between animal and chamber [17, 18] . Furthermore, Kunming mice of either sex were tested by Li et al. [3] , whereas male C57BL/6J mice are examined herein. Interestingly, HA administered at a dosage of 600 mol/kg resulted in a trend towards an increased hypoxic response ( fig. 2 ). To our knowledge, this is the first time that this dosage has been tested in vivo. The discrepant effect of HA on hypoxic responsiveness is interesting and could result from compensatory synthesis of H 2 S by CSE enzymatic activity or effects of HA at this dosage on pathways not utilizing H 2 S.
Of interest, in this study and others [3, 4] , the administration of HSSI such as AOAA, HA and PAG has resulted in decreased responses to hypoxia. One would expect that administration of gaseous H 2 S would achieve the opposite result of those seen with HSSI. However, gaseous H 2 S administration has also been found to reduce the ventilatory response to hypoxia [19] . These counterintuitive findings indicate that pharmacologic modulation of H 2 S synthesis is complex, and further research is needed to elucidate the systemic effects of HSSI on H 2 S levels at the loci of chemosensitivity and respiratory control. Hypoxia-induced anapyrexia is the decrease in temperature noted when a mammal or bird is exposed to hypoxia [20] , and it was noted in each group. Of interest, the animal group with a significantly diminished hypoxic f, V T and V E response compared to saline, AOAA, was the only group to experience a significantly more marked anapyrexia than saline. No temperature difference from saline was noted when AOAA was administered without hypoxic exposure. Therefore, it is likely that hypoxia-induced anapyrexia is responsible for the temperature differences between AOAA and saline.
Hypoxia-induced anapyrexia is thought to be caused by a change in hypothalamic set point [19] , and it is possible that effects at the level of the hypthalamus contributed to both the hypoxic ventilatory response in the AOAA treatment group and the ability of the two systemically administered drugs to enhance hypoxia-induced anapyrexia.
The lack of a consistent effect of the HSSI on hypoxic response illustrates that the reduction in apneic activity among AOAA and HA is likely not solely due to a reduction in ventilatory overshoot-induced hypocapnia. This has previously been demonstrated as a potential etiology for recurrent apneas dependent on peripheral chemoreceptor function [21] . Instead, there may be interactions among peripheral and central mechanisms responsible for respiratory patterning of rate and depth.
An increase in posthypoxic stability, defined by a reduced CV, was observed with the use of CBS inhibitor AOAA, but not the CSE inhibitor PAG. Furthermore, decreased apneic activity was also only seen with the CBS inhibitors HA and AOAA. CBS is found in abundance in the brain [22] , whereas little of CSE is primarily found peripherally with limited expression in the central nervous system [23] . Inhibition and activation of CBS have been found to decrease and increase the frequency of rhythmic meduallary respiratory activity, respectively [5] . At rest, no differences were found amongst the HSSI agents compared to saline in the number of animals expressing one or more apneas, but injection of the CBS inhibitor HA (300 mol/kg) resulted in a trend towards increased stability. This finding suggests that the ability of CBS inhibitors to improve respiratory stability is more marked in the posthypoxic period as opposed to at rest.
Limitations
This study possesses several limitations. First, although this study demonstrates that HSSI agents can affect respiratory stability in the B6 mouse, the location of this systemic effect is unable to be determined by the current data. Second, the use of unrestrained whole body plethysmography is also limiting, because, as stated above, this method tends to accurately record f, but not V T [17, 18] . Third, although our study does make use of postexposure rectal temperature recordings, the lack of continuous measurements during the challenges hampers our ability to make more conclusive remarks on hypoxia-induced anapyrexia between the various administrations; manipulation of the animals during plethysmography testing was avoided so as not to impact our primary outcome, posthypoxic ventilatory behavior. Fourth, our use of only one strain of mouse limits the ability to generalize our results to other strains or species. Finally, the HSSI agents used have poor selectivity for CBS and CSE [24] , but unfortunately selective agents are not currently available and, like other studies examining H 2 S inhibition [3, 4, 25] , multiple inhibitors are used in the current investigation to mitigate this lack of selectivity.
Conclusion and Future Directions
This study demonstrates the in vivo ability of HSSIs targeting different the CBS enzymatic pathways to result in increased ventilatory stability in the post-hypoxic period. Furthermore, CBS, but not CSE, inhibition results in increased ventilatory stability at rest. While the manner and location(s) along the respiratory control axis at which these effects take place are unknown, such a model gives insight into the coupling of chemosensation and stability that may lead to better design of pharmacologic agents to target clinical disorders of ventilatory control.
